NCT05635851View on ClinicalTrials.gov

NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Spinal Cord InjuriesAutonomic Dysreflexia
Interventions
DRUG

Glyceryl Trinitrate Only Product in Oromucosal Dose Form

Glyceryl trinitrate will be administered via sublingual spray.

OTHER

Placebo sublingual spray

A placebo sublingual spray will be administered.

All Listed Sponsors
collaborator

University of British Columbia

OTHER

lead

Simon Fraser University

OTHER